Federal Register / Vol. 88, No. 246 / Tuesday, December 26, 2023 / Notices 88915 

ENVIRONMENTAL PROTECTION 

AGENCY 

[EPA–HQ–OPPT–2017–0127; FRL–11623– 

01–OCSPP] 

2023 Report; Inventory of Mercury 

Supply, Use, and Trade in the United 

States; Notice of Availability 

AGENCY: Environmental Protection 

Agency (EPA). 

ACTION: Notice. 

SUMMARY: The Environmental Protection 

Agency (EPA) is announcing the 

availability of the 2023 mercury 

inventory report, which summarizes 

information on mercury supply, use, 

and trade in the United States that is 

required to be reported to EPA by rule 

directly from mercury manufacturers, 

importers, and processors. The Toxic 

Substances Control Act (TSCA) directs 

the EPA to carry out and publish in the 

Federal Register every three years an 

inventory of mercury supply, use, and 

trade in the United States. TSCA defines 

‘‘mercury’’ as ‘‘elemental mercury’’ or 

‘‘a mercury compound.’’ 

ADDRESSES: The docket for this action, 

identified by docket identification (ID) 

number EPA–HQ–OPPT–2017–0127, is 

available online at http://

www.regulations.gov. Additional 

instructions for visiting the docket, 

along with more information about 

dockets generally, is available at https:// 

www.epa.gov/dockets. 

FOR FURTHER INFORMATION CONTACT: 

For technical information contact: 

Thomas Groeneveld, Existing Chemicals 

Risk Management Division, Office of 

Pollution Prevention and Toxics, 

Environmental Protection Agency, 1200 

Pennsylvania Ave. NW, Washington, DC 

20460–0001; telephone number: (202) 

566–1188; email address: 

groeneveld.thomas@epa.gov. 

For general information contact: The 

TSCA-Hotline, ABVI-Goodwill, 422 

South Clinton Ave., Rochester, NY 

14620; telephone number: (202) 554– 

1404; email address: TSCA-Hotline@

epa.gov. 

SUPPLEMENTARY INFORMATION: 

I. Does this action apply to me? 

This action applies to the public in 

general and may be of interest to a wide 

range of stakeholders including 

members of the public interested in 

elemental mercury or mercury 

compounds generally. Other topics of 

interest include the supply, use, or trade 

of elemental mercury or mercury 

compounds, including mercury-added 

products and manufacturing processes. 

As such, the Agency has not attempted 

to describe all the specific entities that 

may be interested in this action. 

II. What is the Agency’s authority for 

taking this action? 

TSCA section 8(b)(10), 15 U.S.C. 

2507(b)(10), directs EPA to carry out 

and publish in the Federal Register not 

later than April 1, 2017, and every three 

years thereafter, an inventory of 

mercury supply, use, and trade in the 

United States. TSCA section 8(b)(10)(A) 

defines ‘‘mercury’’ as ‘‘elemental 

mercury’’ or ‘‘a mercury compound’’ (15 

U.S.C. 2507(b)(10)(A)). In carrying out 

the mercury inventory, EPA is to 

‘‘identify any manufacturing processes 

or products that intentionally add 

mercury’’ (15 U.S.C. 2607(b)(10)(C)(i)) 

and ‘‘recommend actions, including 

proposed revisions of Federal law or 

regulations, to achieve further 

reductions in mercury use’’ (15 U.S.C. 

2607(b)(10)(C)(ii)). 

III. What action is the Agency taking? 

EPA is publishing the 2023 report of 

the inventory of mercury supply, use, 

and trade in the United States (15 U.S.C. 

2507(b)(10)(B)). This is the second 

report in which the supply, use, and 

trade of mercury is presented based on 

data collected by EPA under the 

mercury reporting requirements under 

TSCA that are codified in 40 CFR part 

713. Persons subject to the reporting 

requirements in 40 CFR part 713 

submitted information directly to EPA 

via the Mercury Electronic Reporting 

(MER) application, which is accessed 

through the Agency’s Central Data 

Exchange (CDX). For reporting activities 

that occurred in the calendar year 2021, 

the deadline for reporting mercury 

information to EPA was July 1, 2022, 

and the inventory collection, reporting, 

and publication cycle will continue 

every three years thereafter. 

IV. How can I access this report? 

The 2023 inventory report, and the 

previously published report in 2020, 

may be found in the docket for this 

action and on the EPA mercury website 

at https://www.epa.gov/mercury. 

Authority: 15 U.S.C. 2607(b)(10)(B). 

Dated: December 20, 2023. 

Michal Freedhoff, 

Assistant Administrator, Office of Chemical 

Safety and Pollution Prevention. 

[FR Doc. 2023–28376 Filed 12–22–23; 8:45 am] 

BILLING CODE 6560–50–P 

ENVIRONMENTAL PROTECTION 

AGENCY 

[EPA–HQ–OPPT–2023–0312; FRL 11015– 

01–OCSPP] 

4,4′-Methylene bis(2-chloroaniline); 

Request Under the Toxic Substances 

Control Act (TSCA) for Records and 

Reports of Significant Adverse 

Reactions to Health or the 

Environment 

AGENCY: Environmental Protection 

Agency (EPA). 

ACTION: Notice. 

SUMMARY: Through this notice, the 

Environmental Protection Agency (EPA) 

is requiring manufacturers (including 

importers) and processors of the 

chemical substance 4,4′-methylene 

bis(2-chloroaniline) to submit the 

records and reports of allegations that 

this chemical substance causes 

significant adverse reactions to health or 

the environment that they are required 

to maintain and submit to EPA when 

requested under the Toxic Substances 

Control Act (TSCA). Information 

submitted to the Agency in response to 

this notice will help inform future EPA 

activities regarding this chemical, 

including aiding EPA activities related 

to this chemical substance having been 

identified as a candidate for designation 

as a High-Priority Substance for TSCA 

risk evaluation. 

DATES: Records must be received by 

EPA on or before February 26, 2024. 

ADDRESSES: The docket for this action, 

identified by docket identification (ID) 

number EPA HQ–OPPT–2023–0312, is 

available online at https://

www.regulations.gov or in person at the 

Office of Pollution Prevention and 

Toxics Docket (OPPT Docket) in the 

Environmental Protection Agency 

Docket Center (EPA/DC). Additional 

instructions on visiting the docket, 

along with more information about 

dockets generally, are available at 

https://www.epa.gov/dockets. 

FOR FURTHER INFORMATION CONTACT: 

Brian Barone, Data Gathering and 

Analysis Division (7406M), Office of 

Pollution Prevention and Toxics, 

Environmental Protection Agency, 1200 

Pennsylvania Ave. NW, Washington, DC 

20460–0001; telephone number: (202) 

566–0233; email address: barone.brian@

epa.gov. 

SUPPLEMENTARY INFORMATION: 

I. Executive Summary 

A. What action is the Agency taking? 

EPA is requiring submission of TSCA 

section 8(c) records of allegations of 

significant adverse reactions to health or 


khammond on DSKJM1Z7X2PROD with NOTICES
88916 Federal Register / Vol. 88, No. 246 / Tuesday, December 26, 2023 / Notices 

the environment for the listed chemical. 

Regulations specifying TSCA section 

8(c) recordkeeping and reporting 

requirements are codified at 40 CFR part 

717. Pursuant to TSCA section 8(c) and 

40 CFR 717.17(b), each person who is 

required to maintain records under 

TSCA section 8(c) and implementing 

regulations at 40 CFR part 717 shall 

submit copies of such records to EPA 

upon request. EPA is issuing this TSCA 

section 8(c) action so that the health and 

environmental risks from exposure to 

this chemical substance can be 

evaluated. The submitted information is 

expected to be used to corroborate 

suspected adverse health or 

environmental effects of the chemical 

under review and to help identify trends 

of adverse effects across the industry 

that may not be apparent to any one 

chemical company. 

EPA has initiated the prioritization 

process for this chemical substance as a 

candidate for designation as a HighPriority Substance for risk evaluation. 

EPA plans to use data received through 

this request to support the prioritization 

process to better understand suspected 

adverse health or environmental effects 

of the chemical. Further, should EPA 

finalize the designation of this chemical 

as a high-priority substance for risk 

evaluation, then gathering this type of 

data before EPA initiates such a risk 

evaluation could help make the risk 

evaluation process more efficient and 

focused. EPA anticipates issuing 

additional TSCA section 8(c) 

submission requirements for other 

chemical substances identified as 

candidates for prioritization. EPA is 

using this TSCA section 8(c) submission 

requirement as a first pilot step in 

making use of the TSCA section 8(c) 

data gathering authority as part of the 

general candidate selection process to 

be used by EPA for TSCA section 6 

prioritization activities. 

B. What is the Agency’s authority for 

taking this action? 

Under TSCA section 8(c), chemical 

manufacturers (including importers) 

and processors must maintain records of 

significant adverse reactions to health or 

the environment alleged to have been 

caused by chemical substances or 

mixtures and, upon request, submit or 

make the records available to the 

Agency. Significant adverse reactions 

are reactions that may indicate a 

substantial impairment of normal 

activities or long-lasting or irreversible 

damage to health or the environment. 

Regulations implementing TSCA section 

8(c) appear in 40 CFR part 717. 

C. Does this action apply to me? 

This action may potentially affect you 

if you manufacture (defined under 

TSCA to include import) or process the 

chemical substance described by this 

document. The following list of North 

American Industry Classification 

System (NAICS) codes is neither 

intended to be exhaustive nor indicate 

expected reporting from a given 

industry sector but rather provides a 

guide to help readers determine whether 

this document applies to them. 

Potentially affected entities may 

include: 

• Manufacturing (NAICS codes 31– 

33), and/or 

• Other Chemical and Allied 

Products Merchant Wholesalers (NAICS 

code 424690). 

Other types of entities not included 

could also be affected. To determine 

whether your entity is affected by this 

action, you should carefully examine 

the applicability criteria found in 40 

CFR part 717. If you have questions 

regarding the applicability of this action 

to a particular entity or information 

regarding additional entities that may 

not be listed in this Notice, please 

consult the person listed in the FOR

FURTHER INFORMATION CONTACT section. 

D. What is 4,4′-methylene bis(2- 

chloroaniline) (MBOCA)? 

MBOCA is used as a curing agent for 

liquid polyurethane elastomers. These 

elastomers have been used to produce 

shoe soles; rolls for postage stamp 

machines; cutting bars in plywood 

manufacturing; rolls and belt drives in 

cameras, computers, and reproducing 

equipment; and pulleys for escalators 

and elevators. Animal studies have 

reported effects on the lung, liver, and 

kidney from chronic oral exposure to 

MBOCA. Animal studies have reported 

that MBOCA produces tumors of the 

liver, lung, urinary bladder, and 

mammary glands from oral exposure. 

EPA has classified MBOCA as a Group 

B2, probable human carcinogen. 

II. Request for TSCA Section 8(c) 

Records 

A. Who must submit records? 

This requirement to submit TSCA 

section 8(c) allegation records applies to 

persons who manufacture (defined 

under TSCA to include import) or 

process MBOCA, and who are subject to 

TSCA section 8(c) recordkeeping 

requirements pursuant to 40 CFR 717.5. 

The regulations provide limited 

exemptions from recordkeeping and 

reporting requirements for certain 

manufacturers and sites of manufacture, 

as described at 40 CFR 717.5(a)(1) and 

717.7(a). Persons or site activities are 

exempt pursuant to 40 CFR 717.7(a)(1) 

if the means by which they manufacture 

a chemical substance solely involves 

mining or other solely extractive 

functions, e.g., those companies or sites 

within a company whose sole function 

is to mine mineral ores, extract 

petroleum or natural gas, quarry nonmetallic minerals (including extraction 

of salts from seawater or brines), mine 

or otherwise extract coal, or separate 

gases from the atmosphere. In addition, 

the regulations exempt persons whose 

only manufacturing act is to produce a 

substance coincidentally under specific 

circumstances, as described in 40 CFR 

717.7(a)(2). 

Two types of processors (who are not 

also manufacturers) are subject to TSCA 

section 8(c) recordkeeping under the 

regulations at 40 CFR 717.5(b)(1) and to 

reporting under this notice: those who 

produce and market chemical mixtures 

(including solutions) and those who 

repackage chemical substances or 

mixtures. 

A person solely engaged in the 

distribution of chemical substances is 

exempt from TSCA section 8(c) 

recordkeeping and reporting pursuant to 

40 CFR 717.7(c) unless such person is 

also a manufacturer or processor subject 

to the regulations. For example, a 

‘‘distributor’’ who repackages chemical 

substances or mixtures is considered to 

be a processor and, thus, is not a sole 

distributor. 

Similarly, pursuant to 40 CFR 

717.7(d), a person who is a retailer is 

exempt from TSCA section 8(c) 

recordkeeping and reporting unless 

such person is also a manufacturer or a 

processor subject to this request. 

B. What types of records must be 

submitted? 

TSCA section 8(c) requires any 

manufacturer, processor, or distributor 

of a chemical substance or mixture to 

keep records of ‘‘significant adverse 

reactions’’ to health or the environment, 

as determined by rule, alleged to have 

been caused by the chemical substance 

or mixture. Implementing regulations at 

40 CFR part 717 describe the types of 

records that must be kept and are briefly 

summarized here. 

A ‘‘significant adverse reactions’’ is 

defined in 40 CFR 717.3(i) as reactions 

that may indicate a substantial 

impairment of normal activities, or longlasting or irreversible damage to health 

or the environment. Allegations subject 

to the recordkeeping requirement are 

described at 40 CFR 717.10. 

‘‘Allegation’’ is defined at 40 CFR 

717.3(a) to mean a statement, made 

without formal proof or regard for 


khammond on DSKJM1Z7X2PROD with NOTICES
Federal Register / Vol. 88, No. 246 / Tuesday, December 26, 2023 / Notices 88917 

evidence, that a chemical substance or 

mixture has caused a significant adverse 

reaction to health or the environment. 

Significant adverse reactions to 

human health that must be recorded 

could include, but are not limited to, 

birth defects, impairment of bodily 

functions, or impairment of normal 

activities, as described at 40 CFR 

717.12(a). TSCA section 8(c) allegations 

may focus on serious health effects, but 

they can also report lesser effects 

experienced by a group of individuals or 

repeatedly by an individual. Allegations 

that do not meet the definition of a 

‘‘significant adverse reaction’’ should 

not be reported to EPA in the TSCA 

section 8(c) call-in. Additionally, the 

regulation at 40 CFR 717.12(b) exempts 

‘‘known human effects’’ from this 

recordkeeping requirement. The 

definition of ‘‘known human effects’’ at 

40 CFR 717.3(c) covers commonly 

recognized human health effects 

resulting from exposure to a substance 

as described in publicly available 

sources such as Safety Data Sheets 

(SDS), product labeling, or scientific 

literature, including, but not limited to, 

information found at the Agency for 

Toxic Substances Disease Registry 

website available at https://

www.atsdr.cdc.gov/index.html and 

EPA’s Integrated Risk Management 

System available at https://

www.epa.gov/iris. However, pursuant to 

40 CFR 717.3(c)(2), the exemption does 

not apply if the reaction was a 

significantly more severe toxic effect 

than previously described, or if the 

reaction resulted from a lower exposure 

level, a significantly shorter exposure 

period, or a different exposure route 

than previously described. 

Significant adverse reactions to the 

environment must also be recorded even 

if restricted to the environment 

surrounding a plant or disposal site. 

Pursuant to 40 CFR 717.12(c), such 

reactions could include but are not 

limited to: gradual or sudden changes to 

composition of animal or plant life, 

deaths of organisms such as fish kills, 

reduction of reproductive success of 

species, changes in behavior or 

distribution of species, loss of 

agricultural productivity, and 

irreversible contamination of the 

environment. 

Pursuant to 40 CFR 717.12(d), a 

significant adverse reaction to the 

environment is not required to be 

recorded if the alleged cause is directly 

attributable to an incident of 

environmental contamination that has 

already been reported to the Federal 

government under any applicable 

authority. 

EPA is requiring submission of all 

TSCA section 8(c) records that fall 

within the record retention period 

described in TSCA section 8(c) and 40 

CFR 717.15(d). Accordingly, this request 

for records includes: 

• Records of significant adverse 

reactions to the health of employees first 

reported to or known by the person 

maintaining such records within the 

past 30 years, including employee 

health-related allegations arising from 

any employment-related exposure, 

whether or not such allegation was 

submitted by or on the behalf of that 

recordkeeper’s own employee. 

• Any other record of significant 

adverse reactions first reported to or 

known by the person maintaining the 

record within the past five years. 

C. What information must be included 

with a submission? 

Manufacturers of the chemical 

substance listed in this notice must 

submit any records kept pursuant to 40 

CFR part 717 of significant adverse 

reactions alleged to have been caused by 

the chemical substance. Under the 

regulations, a manufacturer is 

responsible for collecting allegations 

regarding substances it manufactures, as 

well as allegations regarding certain 

chemical processing and distribution 

activities it may carry out. Accordingly, 

as provided in 40 CFR 717.5(a)(2), 

manufacturers of the listed chemical 

substance must submit records of any 

collected allegations that: 

• Identify the listed chemical 

substance or identify operations used in 

the manufacture of the chemical 

substance; 

• Identify any of the manufacturer’s 

own processing or distribution in 

commerce activities with respect to the 

chemical substance; 

• Identify emissions, effluents, or 

other discharges from activities 

described in this paragraph; and 

• Identify a substance produced 

coincidentally during processing, use, 

storage or disposal of a chemical 

substance it manufactures, where either 

the coincidentally produced chemical 

substance or the originally 

manufactured chemical substance is 

listed in this notice. 

Processors of the chemical substance 

listed in this notice who are subject to 

TSCA section 8(c) recordkeeping 

requirements (i.e., persons who process 

chemical substances to produce 

mixtures, or repackage chemical 

substances or mixtures) must also 

submit any records kept pursuant to 40 

CFR part 717 of significant adverse 

reactions alleged to have been caused by 

the chemical substance. As provided by 

40 CFR 717.5(b)(2), this includes 

allegations that: 

• Identify any mixture the processor 

produces and distributes in commerce 

containing the listed chemical 

substance, or identify the listed 

chemical substance or mixture 

containing the listed chemical substance 

that the processor repackages and 

distributes in commerce; 

• Identify any of the processor’s own 

further processing or distribution in 

commerce activities of such products; 

• Identify emissions, effluents, or 

other discharges from activities 

described in this paragraph; 

• Identify a substance produced 

coincidentally during the processing, 

use, storage, or disposal of any mixture 

the processor produces and distributes 

in commerce or any chemical substance 

or mixture it repackages and distributes 

in commerce, where either the 

coincidentally produced chemical 

substance or the processed chemical 

substance is listed in this notice. 

As provided by 40 CFR 717.15(b), in 

addition to the original allegation as 

received, TSCA section 8(c) reported 

allegation records must contain the 

name and address of the site that 

received the allegation; the date the 

allegation was received; the implicated 

chemical substance, mixture, article, 

company process or operation, or site 

discharge; a description of the alleger; 

and a description of the alleged health 

effect(s) and/or environmental effect(s). 

Additionally, the submission must 

include the results of any self-initiated 

investigation with respect to an 

allegation and copies of any further 

required records or reports relating to 

the allegation, as described at 40 CFR 

717.15(b)(3) and (4)). 

EPA encourages respondents to 

conduct a thorough review of their 

TSCA 8(c) records, including a search 

for all known synonyms and trade 

names associated with the listed 

chemical. Alternative identifiers can be 

found through many sources, including 

PubChem, an open chemistry database 

operated by the National Institutes of 

Health (NIH) at https://pubchem.ncbi.

nlm.nih.gov, EPA’s CompTox Chemical 

Dashboard website at https://comptox.

epa.gov/dashboard and EPA’s 

Substance Registry Service (SRS) at 

https://cdxapps.epa.gov/oms-substanceregistry-services/search. 

D. How does this request for allegation 

records differ from TSCA section 8(e) 

reporting? 

TSCA section 8(e) requires 

manufacturers, processors, and 

distributors of a chemical substance or 

mixture to notify EPA immediately of 


khammond on DSKJM1Z7X2PROD with NOTICES
88918 Federal Register / Vol. 88, No. 246 / Tuesday, December 26, 2023 / Notices 

information that reasonably supports 

the conclusion that such substance or 

mixture presents a substantial risk of 

injury to health or the environment, 

unless that person knows that EPA has 

already been informed. EPA published a 

TSCA section 8(e) Policy Statement and 

Guidance on June 3, 2003 (68 FR 33129 

(FRL–7287–4)), which defines 

‘‘substantial-risk information’’ as 

information which reasonably supports 

the conclusion that a chemical 

substance or mixture presents a 

substantial risk of injury to health or the 

environment, and ‘‘substantial risk of 

injury to health or the environment’’ as 

a risk of considerable concern because 

of the seriousness of the effect, and the 

fact or probability of its occurrence— 

without consideration for economic or 

social benefits of use or costs of 

restricting use. Information related to 

serious toxic effects should be reported 

regardless of exposure. Unlike records 

maintained under TSCA section 8(c), 

which need only be submitted to EPA 

upon request, TSCA requires that 

information required by TSCA section 

8(e) be reported ‘‘immediately’’ (i.e., 

within 30 days of obtaining the 

information). 

The source of the information 

handled under TSCA sections 8(c) and 

8(e) is also different. While allegations 

recorded pursuant to TSCA section 8(c) 

are likely to be received directly from 

workers, consumers, and plant 

neighbors, TSCA section 8(e) 

submissions usually result from 

designed, controlled studies and reports 

strongly implicating a chemical. TSCA 

section 8(e) health effects submissions 

focus on new serious health effects. 

TSCA section 8(e) reporting 

requirements are also triggered by 

information about significant changes in 

exposure circumstances with a 

recognized hazardous substance, which 

may be identified through monitoring 

studies or other means. TSCA section 

8(c) allegations may focus on serious 

health effects, but they can also report 

lesser effects experienced by a group of 

individuals, or repeatedly by an 

individual. 

E. How to report? 

All submitters must report TSCA 

section 8(c) data electronically, using 

the CSPP: Submissions for Chemical 

Safety and Pesticide Programs software 

(CSPP Software) accessible via EPA’s 

Central Data Exchange (CDX) system 

available at https://cdx.epa.gov/. The 

CSPP Software provides a TSCA 

Communications application that a 

registered CDX user will access to 

submit TSCA section 8(c) records. 

Guidance on how to submit TSCA 

section 8(c) data is available in the 

docket (EPA–HQ–OPPT–2023–0312) 

and via EPA’s TSCA section 8(c) web 

page for this action at https://

www.epa.gov/assessing-and-managingchemicals-under-tsca/tsca-8c-reporting44-methylene-bis2-chloroaniline-mboca. 

You may also obtain help by contacting 

EPA’s TSCA Hotline at tsca-hotline@

epa.gov or 202–554–1404. For help with 

accessing your CDX account, please 

contact the CDX help desk at https://

cdx.epa.gov/contact or (888) 890–1995 

(for international callers: (970) 494– 

5500). 

F. How to submit confidential business 

information? 

Any person submitting copies of 

records may assert a business 

confidentiality claim covering all or part 

of the submitted information in 

accordance with the procedures 

described in 40 CFR part 703 (88 FR 

37155, June 7, 2023 (FRL–8223–02– 

OCSPP)). 

Requirements for asserting and 

maintaining confidentiality claims are 

described in 40 CFR 703.5. Such claim 

must be made concurrent with 

submission of the information. If no 

such claim accompanies the 

submission, EPA will not recognize a 

confidentiality claim, and the 

information in that submission may be 

made available to the public without 

further notice. Confidentiality claims 

must be substantiated at the time of 

submission to EPA pursuant to the 

requirements of 40 CFR 703.5(b). To 

assert a claim of confidentiality for 

information contained in a submitted 

record, the respondent must submit two 

copies of the document. One copy must 

be complete. In that copy, the 

respondent must indicate what 

information, if any, is claimed as 

confidential by marking the specific 

information on each page with a label 

such as ‘‘confidential’’, ‘‘proprietary’’, or 

‘‘CBI.’’ The other copy must be a public 

version of the submission and 

attachments, with all information that is 

claimed as confidential removed. See 40 

CFR 703.5(c). Both the copy containing 

information claimed as CBI and the 

‘‘sanitized’’ copy must be submitted 

electronically, as discussed in Unit II.F. 

The TSCA Communications Tool 

incorporates many of the requirements 

for asserting CBI claims, including 

substantiation questions, a required 

certification statement, and prompts to 

provide a sanitized copy. Further details 

regarding the requirements for 

confidentiality claims can be found in 

40 CFR part 703. 

G. When is reporting not required? 

As provided by 40 CFR part 717, 

reporting is not required by certain 

persons for certain types of activities 

involving the chemical, including: 

• Entities considered manufacturers 

solely due to mining or other resource 

extraction activities are not required to 

report (40 CFR 717.7(a)(1)); 

• Persons whose sole manufacturing 

is due to the incidental or coincidental 

production of chemical substances in 

certain circumstances are not required 

to report (40 CFR 717.7(a)(2)(i)–(v)); 

• Processors are required to report 

only if they process chemical substances 

to produce mixtures or repackage 

chemical substances or mixtures (40 

CFR 717.5(b)(1)); 

• A person solely engaged in the 

distribution of chemical substances is 

exempt from 8(c) reporting, unless such 

person is also a manufacturer or 

processor subject to 8(c) requirements 

(40 CFR 717.7(c)); and 

• A person who is a retailer is exempt 

from 8(c) reporting unless such person 

is also a manufacturer or a processor 

subject to 8(c) requirements (40 CFR 

717.7(d)). 

Known human effects (i.e., commonly 

recognized human health effects in 

literature or product labels/SDS) need 

not be reported unless the effect is 

significantly more severe, occurred after 

a significantly shorter exposure period 

or lower exposure level, or occurred due 

to a different exposure route than 

previously described (see 40 CFR 

717.12(b) and 717.3(c) for details). 

Additionally, firms are not required to 

record a significant adverse reaction to 

the environment if the alleged cause of 

that significant adverse reaction can be 

directly attributable to an accidental 

spill or other accidental discharge, 

emission exceeding permitted limits, or 

other incident of environmental 

contamination that has been reported to 

the Federal Government under any 

applicable authority (40 CFR 717.12(d)). 

III. Paperwork Reduction Act (PRA) 

According to PRA, 44 U.S.C. 3501 et 

seq., an agency may not conduct or 

sponsor, and a person is not required to 

respond to a collection of information 

that requires Office of Management and 

Budget (OMB) approval under the PRA, 

unless it has been approved by OMB 

and displays a currently valid OMB 

control number. The OMB control 

numbers for EPA’s regulations in title 40 

of the CFR, after appearing in the 

Federal Register, are listed in 40 CFR 

part 9, and included on the related 

collection instrument or form, if 

applicable. 


khammond on DSKJM1Z7X2PROD with NOTICES
Federal Register / Vol. 88, No. 246 / Tuesday, December 26, 2023 / Notices 88919 

The information collection 

requirements associated with records of 

allegations of significant adverse 

reactions to human health or the 

environment under TSCA section 8(c) 

are contained in 40 CFR part 717 (OMB 

Control No. 2070–0224; EPA ICR No. 

2703.01) approved by OMB on 

November 23, 2022. This action does 

not impose any burden requiring 

additional OMB approval. The annual 

paperwork burden per respondent is 

estimated to be 12.25 hours. This 

burden estimate includes the time 

needed to maintain records of 

allegations of significant adverse 

reactions, submit copies of these 

allegation records when required by 

EPA, and review of the Federal Register 

notice. For additional details, please see 

the Information Collection Request 

document that is available in the docket. 

Authority: 15 U.S.C. 2607(c). 

Dated: December 19, 2023. 

Michal Freedhoff, 

Assistant Administrator, Office of Chemical 

Safety and Pollution Prevention. 

[FR Doc. 2023–28299 Filed 12–22–23; 8:45 am] 

BILLING CODE P 

FEDERAL DEPOSIT INSURANCE 

CORPORATION 

Sunshine Act Meetings 

TIME AND DATE: 3:12 p.m. on Wednesday, 

December 20, 2023. 

PLACE: The meeting was held in the 

Board Room located on the sixth floor 

of the FDIC Building located at 550 17th 

Street NW, Washington, DC. 

STATUS: Closed. 

MATTERS TO BE CONSIDERED: The Board 

of Directors of the Federal Deposit 

Insurance Corporation met to consider 

matters related to the Corporation’s 

supervision, corporate, and resolution 

activities. In calling the meeting, the 

Board determined, on motion of 

Director Rohit Chopra (Director, 

Consumer Financial Protection Bureau), 

seconded by Director Michael J. Hsu 

(Acting Comptroller of the Currency), 

and concurred in by Vice Chairman 

Travis J. Hill, Director Jonathan P. 

McKernan, and Chairman Martin J. 

Gruenberg, that the public interest did 

not require consideration of the matters 

in a meeting open to public observation; 

and that the matters could be 

considered in a closed meeting by 

authority of subsections (c)(2), (c)(4), 

(c)(6), (c)(8), (c)(9)(A)(ii), (c)(9)(B), and 

(c)10 of the ‘‘Government in the 

Sunshine Act’’ (5 U.S.C. 552b (c)(2), 

(c)(4), (c)(6), (c)(8), (c)(9)(A)(ii), (c)(9)(B) 

and (c)(10)). 

CONTACT PERSON FOR MORE INFORMATION: 

Requests for further information 

concerning the meeting may be directed 

to Debra A. Decker, Executive Secretary 

of the Corporation, at 202–898–8748. 

Dated this the 20th day of December, 2023. 

Federal Deposit Insurance Corporation. 

James P. Sheesley, 

Assistant Executive Secretary. 

[FR Doc. 2023–28472 Filed 12–21–23; 8:45 am] 

BILLING CODE 6714–01–P 

FEDERAL FINANCIAL INSTITUTIONS 

EXAMINATION COUNCIL 

[Docket No. AS23–21] 

Appraisal Subcommittee; Notice of 

Meeting 

AGENCY: Appraisal Subcommittee of the 

Federal Financial Institutions 

Examination Council. 

ACTION: Notice of special closed 

meeting. 

Description: In accordance with 

section 1104(b) of title XI of the 

Financial Institutions Reform, Recovery, 

and Enforcement Act of 1989, as 

amended, notice is hereby given that the 

Appraisal Subcommittee (ASC) met for 

a special closed meeting on this date. 

Location: Virtual meeting via Webex. 

Date: December 14, 2023. 

Time: 10:30 a.m. ET. 

Action and Discussion Item 

Personnel Matter 

The ASC convened a Special Closed 

Meeting to discuss a personnel matter. 

No action was taken by the ASC. 

James R. Park, 

Executive Director. 

[FR Doc. 2023–28365 Filed 12–22–23; 8:45 am] 

BILLING CODE 6700–01–P 

FEDERAL RESERVE SYSTEM 

Agency Information Collection 

Activities: Announcement of Board 

Approval Under Delegated Authority 

and Submission to OMB 

AGENCY: Board of Governors of the 

Federal Reserve System. 

SUMMARY: The Board of Governors of the 

Federal Reserve System (Board) is 

adopting a proposal to extend for three 

years, without revision, the Reporting 

and Recordkeeping Requirements 

Associated with Regulation Y (Capital 

Plans) (FR Y–13; OMB No. 7100–0342). 

FOR FURTHER INFORMATION CONTACT: 

Federal Reserve Board Clearance 

Officer—Nuha Elmaghrabi—Office of 

the Chief Data Officer, Board of 

Governors of the Federal Reserve 

System, nuha.elmaghrabi@frb.gov, (202) 

452–3884. 

Office of Management and Budget 

(OMB) Desk Officer for the Federal 

Reserve Board, Office of Information 

and Regulatory Affairs, Office of 

Management and Budget, New 

Executive Office Building, Room 10235, 

725 17th Street NW, Washington, DC 

20503, or by fax to (202) 395–6974. 

SUPPLEMENTARY INFORMATION: On June 

15, 1984, OMB delegated to the Board 

authority under the Paperwork 

Reduction Act (PRA) to approve and 

assign OMB control numbers to 

collections of information conducted or 

sponsored by the Board. Boardapproved collections of information are 

incorporated into the official OMB 

inventory of currently approved 

collections of information. The OMB 

inventory, as well as copies of the PRA 

Submission, supporting statements 

(which contain more detailed 

information about the information 

collections and burden estimates than 

this notice), and approved collection of 

information instrument(s) are available 

at https://www.reginfo.gov/public/do/ 

PRAMain. These documents are also 

available on the Federal Reserve Board’s 

public website at https://www.federal

reserve.gov/apps/reportingforms/home/ 

review or may be requested from the 

agency clearance officer, whose name 

appears above. 

Final Approval Under OMB Delegated 

Authority of the Extension for Three 

Years, Without Revision, of the 

Following Information Collection 

Collection title: Reporting and 

Recordkeeping Requirements 

Associated with Regulation Y (Capital 

Plans). 

Collection identifier: FR Y–13. 

OMB control number: 7100–0342. 

General description of collection: In 

addition to other reporting and 

recordkeeping requirements, Section 

225.8 of Regulation Y—Bank Holding 

Companies and Change in Bank Control 

(12 CFR 225.8) requires respondents to 

submit a capital plan to the Board on an 

annual basis and to request prior 

approval from the Board under certain 

circumstances before making a capital 

distribution. 

Frequency: Annually and on occasion. 

Respondents: Top-tier bank holding 

companies (BHCs) domiciled in the 

United States with $100 billion or more 

in total consolidated assets; U.S. 

intermediate holding companies with 

total consolidated assets of $100 billion 

or more; any other BHC domiciled in 

the United States that is made subject to 


khammond on DSKJM1Z7X2PROD with NOTICES